Search

Search Results

• The role of rank-ligand inhibition in the treatment of postmenopausal osteoporosis

  M. Varenna, D. Gatti

  163-171

  https://doi.org/10.4081/reumatismo.2010.163

  1933

  PDF: 1296

• PO:20:007 | Mind the rebound: ctx dynamics after denosumab discontinuation and zoledronate rescue in patients with postmenopausal osteoporosis or with cancer treatment-induced bone loss Federico Aldegheri¹, Francesca Ruzzon¹, Matteo Appoloni¹, Giovanni Adami¹, Davide Gatti¹, Maurizio Rossini¹, Angelo Fassio¹, Ombretta Viapiana¹ | ¹Università di Verona, Italy

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2342

  31
• 

  Duration of treatment for osteoporosis

  Luca Idolazzi, A. Fassio, D. Gatti, S. Tamanini, O. Viapiana, M. Rossini, S. Adami

  22-35

  28-03-2013

  https://doi.org/10.4081/reumatismo.2013.22

  3905

  PDF: 1313
• 

  Safety profile of drugs used in the treatment of osteoporosis: a systematical review of the literature

  M. Varenna, F. Bertoldo, M. Di Monaco, A. Giusti, G. Martini, M. Rossini, On behalf of SIOMMMS, Endorsed by SIR

  143-166

  31-10-2013

  https://doi.org/10.4081/reumatismo.2013.143

  7524

  PDF: 2765

• PO:20:006 | Efficacy of denosumab in glucocorticoid-induced osteoporosis patients with prior exposure to intravenous aminobisphosphonates Kiren Khalid¹, Alessandro Giollo¹, Mariangela Salvato¹, Francesca Frizzera¹, Lorenzo Di Luozzo¹, Bernd Raffeiner², Andrea Doria¹ | ¹Rheumatology Unit, Department of Medicine - DIMED, University of Padova, Padova, Italy; ²Department of Rheumatology, Bolzano Central Hospital, Bolzano, Italy

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2341

  12
• 

  Denosumab for the treatment of HIV-associated osteoporosis with fractures in a premenopausal woman

  E. Marasco, M. Mussa, F. Motta, F. Bobbio-Pallavicini, R. Maserati, C. Montecucco, L. Bogliolo

  54-58

  19-04-2021

  https://doi.org/10.4081/reumatismo.2021.1358

  6078

  PDF: 1005
• 

  Glucocorticoid-induced osteoporosis: 2013 update

  M. Mazzantini, O. Di Munno

  144-152

  28-07-2014

  https://doi.org/10.4081/reumatismo.2014.787

  3839

  PDF: 2335

• Novel genetic mutation associated with hyperphosphatemic familial tumoral calcinosis/hyperostosis-hyperphosphatemia syndrome treated with denosumab: a case report

  G. Fabbriciani, A. Colombini, C. Messina, G. Adami

  24-06-2024

  https://doi.org/10.4081/reumatismo.2024.1687

  1351

  PDF: 596
• 

  Drug-induced osteonecrosis of the jaw: the state of the art

  A. Fassio, F. Bertoldo, L. Idolazzi, O. Viapiana, M. Rossini, D. Gatti

  9-15

  22-05-2017

  https://doi.org/10.4081/reumatismo.2017.983

  5430

  PDF: 3015
• 

  Different fracture risk profile in patients treated with anti-osteoporotic drugs in real-life

  G. Adami, A. Giollo, M. Rossini, G. Orsolini, C. Benini, O. Viapiana, D. Gatti, A. Fassio

  71-74

  23-07-2020

  https://doi.org/10.4081/reumatismo.2020.1267

  1896

  PDF: 1275